Liu Rui, Han Cheng, Wu Di, Xia Xinghai, Gu Jianqiu, Guan Haixia, Shan Zhongyan, Teng Weiping
Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Biomed Res Int. 2015;2015:762820. doi: 10.1155/2015/762820. Epub 2015 Nov 10.
We systematically identified the prevalence of hyperuricemia and gout in mainland China and provided informative data that can be used to create appropriate local public health policies. Relevant articles from 2000 to 2014 were identified by searching 5 electronic databases: PubMed, Google Scholar, Chinese Wanfang, CNKI, and Chongqing VIP. All of the calculations were performed using the Stata 11.0 and SPSS 20.0 software. The eligible articles (n = 36; 3 in English and 33 in Chinese) included 44 studies (38 regarding hyperuricemia and 6 regarding gout). The pooled prevalence of hyperuricemia and gout was 13.3% (95% CI: 11.9%, 14.6%) and 1.1% (95% CI: 0.7%, 1.5%), respectively. Although publication bias was observed, the results did not change after a trim and fill test, indicating that that impact of this bias was likely insignificant. The prevalence of hyperuricemia and gout was high in mainland China. The subgroup analysis suggested that the geographical region, whether the residents dwell in urban or rural and coastal or inland areas, the economic level, and sex may be associated with prevalence.
我们系统地确定了中国大陆高尿酸血症和痛风的患病率,并提供了可用于制定适当地方公共卫生政策的信息数据。通过检索5个电子数据库(PubMed、谷歌学术、中国万方、知网和重庆维普)确定了2000年至2014年的相关文章。所有计算均使用Stata 11.0和SPSS 20.0软件进行。符合条件的文章(n = 36;3篇英文和33篇中文)包括44项研究(38项关于高尿酸血症,6项关于痛风)。高尿酸血症和痛风的合并患病率分别为13.3%(95%CI:11.9%,14.6%)和1.1%(95%CI:0.7%,1.5%)。尽管观察到发表偏倚,但在进行修剪和填充检验后结果并未改变,表明这种偏倚的影响可能微不足道。中国大陆高尿酸血症和痛风的患病率很高。亚组分析表明,地理区域、居民居住在城市还是农村以及沿海还是内陆地区、经济水平和性别可能与患病率有关。